No Picture
News

Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 3, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic,… Click […]

No Picture
News

Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST

ROCKVILLE, Md. and SUZHOU, China, June 2, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune,… Click […]

No Picture
News

FDA Roundup: June 2, 2023

SILVER SPRING, Md., June 2, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA provided an update on medical device […]

No Picture
News

Indivior Reaches Agreement with States’ Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims

RICHMOND, Va., June 2, 2023 /PRNewswire/ — Indivior PLC (LSE: INDV), a leading addiction treatment company, announced that its subsidiary, Indivior Inc. (the “Company”), has reached an agreement to resolve the claims brought by the […]

No Picture
News

Gale to Present the Cameron K. Gallagher Foundation with Charitable Check to Support Student Mental Health & Wellness

RICHMOND, Va., June 2, 2023 /PRNewswire/ — What: Gale, part of Cengage Group, will present the Cameron K. Gallagher (CKG) Foundation with a check for nearly $9,000 from the proceeds of Cameron’s Collection and Cameron’s […]

No Picture
News

UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE RECEIVES ONE OF THE LARGEST GIFTS IN ITS HISTORY TO ESTABLISH KAHLERT INSTITUTE FOR ADDICTION MEDICINE

$10 Million Gift from the Kahlert Foundation to Spur Innovation into New Addiction Treatments and Prevention BALTIMORE, June 2, 2023 /PRNewswire/ — With an urgent mission to address the alarming rise in drug overdose deaths, […]

No Picture
News

Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China

ROCKVILLE, Md. and SUZHOU, China, June 1, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic,… […]

No Picture
News

This Pride Month, NAMI’s ‘Mental Health Without Conditions’ Campaign Gives Voice to the LGBTQ+ Community and Addresses Inequity, Disparities

ARLINGTON, Va., June 1, 2023 /PRNewswire/ — The National Alliance on Mental Illness (NAMI), the nation’s largest grassroots mental health organization, today launched “Mental Health Without Conditions,” a compassionate Pride Month campaign for LGBTQ+ dignity […]